top of page

WOUNDS

Wounds are a major problem in the world. Delayed healing process in chronic wounds can be due to pain and complications from significant comorbidities among others. These wounds which may take months to heal, have an increased risk of infections, amputation and prolonged hospital visits which can also affect the patient’s Quality of Life.

Most chronic wound patients are stuck in the inflammatory phase of healing which will have an adverse effect on their health-related Quality of Life such as pain, restricted mobility, sleep quality, physical function (i.e., one’s sense of physical energy and ability to carry out activities of daily living, such as working and household chores); psychological well-being (i.e., stress which is one of the factors that lead to poor bowel movement,¹  depression, anxiety and fear); social function (i.e., ability to engage in meaningful, interpersonal relationships) and somatic sensation (i.e., one’s disease-related symptoms such as wound pain). ²

Over the decades, Western medicine has focused on pharmaceutical cures for damaged tissues and illnesses. Microcurrent therapy is now gaining popularity as an adjunct wound healing solution for managing wounds thanks to advanced 20th century medical research which has documented the effects of electrotherapy.

Avazzia BEST™ devices are hand-held, battery-operated, non-invasive microcurrent electro-stimulation medical device. The microcurrent interactive feedback and electro-stimulation technology gently stimulate the body’s natural resources to resolve pain, not just mask it.

Avazzia BEST™ (Bio-Electric Stimulation Technology) helps redress an underlying physiological dysfunction as well as reducing its symptoms and features non-invasive neuromodulation (changing signal of nerves). There is no habituation, as the electrical properties of the tissue changes with each signal applied by the device. This concept of biofeedback is dependent on tissue conductivity and independent of the human brain process.

When the body’s endogenous bioelectric system fails and cannot contribute to wound repair processes, exogenous microcurrent stimulation delivered into the wound tissue mimics this failed natural bioelectric currents so that wound healing can proceed. Certain chemotaxic factors found in wound substrates contribute to tissue repair processes by attracting cells into the wound environment. Avazzia BESTTM signals facilitate galvanotaxic attraction of neutrophil, macrophage, fibroblast and epidermal cells involved in wound repair into the wound tissue and thereby accelerate wound healing.³

Microcurrent – regeneration of tissue rather than just wound closure for healing

Inflammatory phase

Electrical Stimulation increases blood flow, tissue oxygenation and stimulates fibroblasts while reducing edema and providing an increased antibacterial effect.

Proliferative phase

Electrical Stimulation increases membrane transport, collagen matrix organization, wound contraction and the stimulation of DNA and protein synthesis.

Remodeling phase

Electrical Stimulation increases epidermal cell proliferation and migration, as well as stimulation of fibroblasts, thus enabling wound closure.

Mode of action for Avazzia BEST™ microcurrent stimulation in accelerating wound healing:

Injured cells resist the body’s natural electric current, preventing the supply of blood, oxygen, and other vital nutrients. The inflammatory barricade keeps free radicals from leaking into surrounding tissues and is also impenetrable to circulating antioxidants.

Induced microcurrent causes electrons to move across the inflammatory barricades and into pockets of inflammation where they neutralize free radicals and at the same time, microcurrent stimulates cellular activity and regeneration by increasing the production of ATP by 500 percent.⁴

Reduce Inflammation

1

Research has found that exogenous electrical stimulus can increase the growth of blood vessel networks by as much as 50 percent.⁵ Exogenous electrical stimulation can change the ionic environment surrounding the endothelial cells, which form the lining of blood vessels.

In other words, Avazzia BEST™ microcurrent stimulation activates the pathway for angiogenesis (formation of new blood vessels), and enhances vascular network growth, which has been shown to increase blood flow rate and promote local blood circulation.

Increase perfusion

2

Research has shown that pulsed electro-magnetic field (PEMF) is effective in improving circulation, accelerating tissue regeneration, reducing inflammation, regulating the nervous system, relieving pain and reducing the wound healing duration.⁶

Avazzia QiWave™ pulsed electro-magnetic field (PEMF) accessory reduces pain sensation partly due to increase in O₂ partial pressure in the terminal tissue and the increase in the local perfusion and velocity of the capillary blood flow. It realigns ions in the damaged cells and eliminates excess fluid and allows for healing to begin.

The potential for the electrical-based treatment of wounds is far-reaching.  Given the targeted, localized nature of such wound treatment, the application of Avazzia BEST™ electrical stimulus could replace or reduce the need for drug-based treatments that affect the entire body and may carry side effects. 

Importantly, such therapy could be applied using a hand-held device without the need to remove the wound dressing.

Naturally occurring electricity in body’s cells is key to healing wounds

A published Wound study conducted in Hospital Kuala Lumpur, Malaysia, in 2017 showed that all one hundred participants showed reduction in wound size. Sixteen participants had 100 percent wound area reduction or complete wound closure whereas seventy participants had 50 percent and above wound area reduction.

Nair, H.K. Microcurrent as an adjunct therapy to accelerate chronic wound healing and reduce patient pain, Journal of Wound Care, 27(5), 296-306, May 2018

Before-After Wound Images using Avazzia BEST™ microcurrent treatment as an adjunct therapy for four (4) weeks.

Right Diabetic Foot Ulcer with Ray’s Amputation done in 2015

  • Wound healed with full epithelialization.

  • Neuropathy pain reduced by 83% resulting in requirement of Tramadol 50mg BD reduced to nil

  • Improved sleep.

  • Patient’s gait improved due to reduction in foot stiffness, numbness and ankle swelling.

  • Foot colour and sensation improved.

  • Improvement in early morning erection and frequency of bowel movement.

Venous Ulcer on Right Lower Limb for >5 months

  • Wound healed with 100% epithelialization.

  • Although pain reduced by 88% and sleep quality improved, patient  maintained his pain medication intake OD.

  • Leg stiffness and swelling reduced causing improvement in gait.

  •  Improvement in leg discolouration

  • Improvement in early morning erection and frequency of bowel movement.

Left Diabetic Foot Ulcer at the lateral plantar aspect for >1 year

  • Wound area reduced 98%.

  • Neuropathy pain reduced by 75% resulting in patient having improved sleep.

  • Foot stiffness and ankle swelling also reduced.

  • Patient used to require wheelchair assistance but after treatment patient, could walk without aid.

  • Noticeable improvement in leg discolouration due to reduction in scar tissues and hyperpigmentation.

  • Improvement in early morning erection and frequency of bowel movement.

Right Diabetic Foot Ulcer with Ray’s Amputation done in 2015

  • Wound healed with full epithelialization.

  • Neuropathy pain reduced by 83% resulting in requirement of Tramadol 50mg BD reduced to nil

  • Improved sleep.

  • Patient’s gait improved due to reduction in foot stiffness, numbness and ankle swelling.

  • Foot colour and sensation improved.

  • Improvement in early morning erection and frequency of bowel movement.

3rd stage sacral sore for >5 months

  • Wound healed with 88% epithelialization.

  • 67% reduction in leg pain.

  • Reduction in leg stiffness causing improvement in gait.

  • Improvement in the quality of sleep.

Venous Ulcer on Left Lower Limb for >5 years

  • Wound healed with full epithelialization.

  • Leg pain reduced by 80%.

  • Leg stiffness and swelling reduced causing improvement in gait.

  • Requirement of Tramadol 50mg BD was reduced to nil.

  • Improvement in leg colour

  • Improvement in early morning erection and frequency of bowel movement.

Right Diabetic Foot Ulcer at the 2nd toe for >4 months
 

  • Wound area reduced by 95%.

  • Neuropathy pain reduced by 75% resulting in improved sleep quality.

  • Foot stiffness and swelling reduced as well as requirement of Tramadol which reduced from 50mg OD to nil.

  • Foot discolouration improved due to improved sensation which led to improved gait.

  • Improvement in bowel movement in terms of frequency as patient previously experienced poor bowel output predominantly.

Nair, H.K. Microcurrent as an adjunct therapy to accelerate chronic wound healing and reduce patient pain, Journal of Wound Care, 27(5), 296-306, May 2018

  1. International Association for the Study of Pain: Unrelieved pain is a major global healthcare problem.

  2. Global Industry Analysts, Inc. Report, http://www.prweb.com/pdfdownload/8052240.pdf.

  3. A Systematic Review of the Prevalence and Measurement of Chronic Pain in Asian Adults Mohamed Zaki L.R., Hairi N.N. (2015) Pain Management Nursing, 16 (3), pp. 440-452.

  4. “Human Bodies Make Their Own Morphine” Christine Dell’Amore, National Geographic News,

  5. Anette Kjellgren, 2003, The experience of floatation REST (restricted environmental stimulation technique), subjective stress and pain, Goteborg University Sweden, Kjellgren A, Sundequist  U et al.. “Effects of flotation-REST on muscle tension pain”. Pain Research and Management 6 (4): 181–9

  6. Wolcott LE, Wheeler PC, Hardwicke HM, and Rowley BA (1969). “Accelerated healing of skin ulcer by electrotherapy: preliminary clinical results”. Southern Medical Journal 62 (7): 795–801.PMID 5306004.

  7. Ng MM, Avazzia Biofeedback Electrostimulation Therapy (Avazzia BEST): Its Effect on Changes in Pain Biomarkers on Chronic Neuropathic Pain: A Prospective Randomised Controlled Trial. In Press 2014.

  8. Spreier J, (2012), “Efficacy of Avazzia BEST Microcurrent Stimulation Device”, Avazzia, Inc., MKT-121214-03

CITATIONS:

bottom of page